Prophylactic Tranexamic Acid Use After Vaginal Delivery

• Status: Completed
• Trial end date: 2022-02-28
• Target enrollment: 0
• Participant gender: Female

Summary

In this study, our aim was to evaluate the effectiveness of prophylactic tranexamic acid use after vaginal delivery in pregnant women aged 18-45 years and 34-42 weeks according to the risk of postpartum hemorrhage.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital
• Collaborator: Sisli Hamidiye Etfal Training and Research Hospital
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• singleton pregnant women

• woman between the ages of 18-45 years

• woman who gave birth at 34 weeks and above

Exclusion Criteria:

• Pregnancies with less than 1 hour period between hospitalization and delivery

• Women with placenta previa, invasion anomaly or diagnosis of abruptio placentae

• Women with previous uterine surgery or cesarean section

• Women with a history of thromboembolism

• women with serious illness